Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine

This study has been completed.
Sponsor:
Information provided by:
VaxGen
ClinicalTrials.gov Identifier:
NCT00103467
First received: February 8, 2005
Last updated: June 23, 2005
Last verified: February 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given